Standout Papers
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective (1995)
- Human papillomavirus and cervical cancer (2007)
- Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia (1993)
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer (2012)
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice (2005)
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels (2013)
- Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial (2001)
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer (2012)
- Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia (2008)
- Carcinogenic human papillomavirus infection (2016)
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer (2012)
- Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women (1994)
- Human Papillomavirus Testing in the Prevention of Cervical Cancer (2011)
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice (2011)
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica (2013)
Immediate Impact
8 by Nobel laureates 6 from Science/Nature 227 standout
Citing Papers
Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature
2024 Standout
Cervical Cancer Screening
2023 Standout
Works of Mark Schiffman being referenced
Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening
2020
Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mark Schiffman | 30890 | 13837 | 8008 | 424 | 36.3k | |
| F. Xavier Bosch | 32441 | 14887 | 8407 | 286 | 42.9k | |
| Rolando Herrero | 22632 | 11619 | 5598 | 344 | 30.0k | |
| Núbia Muñóz | 21110 | 12321 | 5722 | 218 | 29.9k | |
| Robert D. Burk | 22138 | 9895 | 4948 | 471 | 30.5k | |
| Joakim Dillner | 19800 | 7962 | 7281 | 566 | 27.1k | |
| Peter J.F. Snijders | 31658 | 15294 | 9794 | 396 | 42.8k | |
| Eduardo L. Franco | 19341 | 8804 | 6025 | 534 | 27.1k | |
| Philip E. Castle | 20692 | 8960 | 6299 | 339 | 23.8k | |
| Nicolas Wentzensen | 15848 | 7520 | 6560 | 370 | 23.4k | |
| Keerti V. Shah | 17349 | 8194 | 5995 | 184 | 23.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...